UA84351U - USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS - Google Patents
USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUSInfo
- Publication number
- UA84351U UA84351U UAA201212500U UAA201212500U UA84351U UA 84351 U UA84351 U UA 84351U UA A201212500 U UAA201212500 U UA A201212500U UA A201212500 U UAA201212500 U UA A201212500U UA 84351 U UA84351 U UA 84351U
- Authority
- UA
- Ukraine
- Prior art keywords
- nitroxidergic
- phenylethyl
- correction
- amino
- atherosclerosis
- Prior art date
Links
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Use of 1-(phenylethyl)-4-amino-1,2,4-triazolium bromide as active base of medicinal agents for correction of nitroxidergic system dysfunction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201212500U UA84351U (en) | 2012-11-02 | 2012-11-02 | USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201212500U UA84351U (en) | 2012-11-02 | 2012-11-02 | USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84351U true UA84351U (en) | 2013-10-25 |
Family
ID=52339382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201212500U UA84351U (en) | 2012-11-02 | 2012-11-02 | USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA84351U (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2532394C1 (en) * | 2013-10-29 | 2014-11-10 | Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") | USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS |
-
2012
- 2012-11-02 UA UAA201212500U patent/UA84351U/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2532394C1 (en) * | 2013-10-29 | 2014-11-10 | Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") | USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN06714A (en) | ||
MX2013015168A (en) | Glucagon/glp-1 receptor co-agonists. | |
MX347703B (en) | Glucagon/glp-1 receptor co-agonists. | |
EP3010892B8 (en) | 1,2,4-triazoles as nuclear transport modulators and uses thereof | |
EP3030493A4 (en) | Overlay applicator, applicator machine, and cradle, and method of providing and using the same | |
EP2556770A4 (en) | Desk for maintaining correct posture, and system furniture comprising the desk | |
MY181898A (en) | Heterocyclic compounds and uses thereof | |
MX2015013154A (en) | Use of perfusion decellularized liver for islet cell recellularization. | |
GEP20186891B (en) | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | |
TW201144301A (en) | Processes for preparing linezolid | |
IN2013DN02552A (en) | ||
EP2763672A4 (en) | 1,3-substituted azetidine pde10 inhibitors | |
EP3030226A4 (en) | Delivery system for active agents | |
EP2773623A4 (en) | 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof | |
EP3083464A4 (en) | Overlay applicator, applicator machine, and cradle, and method of providing and using the same | |
UA114345C2 (en) | 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}-ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist | |
WO2015164387A3 (en) | Systems, methods, and apparatus for providing machine-to-machine and consumer-to-machine interaction application platforms | |
GB2480888B (en) | Femtocell, communication method for the femtocell, and computer readable medium thereof | |
UA84351U (en) | USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS | |
MX345263B (en) | Stable pexiganan formulation. | |
MX366768B (en) | Orodispersible sildenafil tablet and preparation method thereof. | |
IT1400702B1 (en) | EQUIPMENT FOR PACKING LOADS WITH THERMORETABLE FILM, EQUIPPED WITH ADJUSTABLE BURNERS. | |
UA80811U (en) | ETHYL 3-(3,4-DIMETHYLPHENYL)-6-THIOXO-7-CYANO-1,3,4,6-2H-PYRIDO[1,2-a][1,3,5]TRIAZINE -9-CARBOXYLATE | |
양만표 | Thrombosis | |
HK1190259A1 (en) | Bidirectional communication system, and method for compensating for undesired feedback in the bidirectional communication system |